News and Announcements
YPB Updated Investor Presentation February 2016
- Published February 16, 2016 10:36AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
15th February 2016, ASX Announcement
- 1.7 TRILLION – Current value of global counterfeit trade
- 284 BILLION – Corporate and government spend combating counterfeiting
- 70% – China’s share of counterfeits seized by US customs
- 7% – Estimated share of global trade that is counterfeit
- 300k People die each year from lethal counterfeit pharmaceuticals
Our Purpose
- Protect, Detect, Connect
- We provide Certainty of Authenticity to Brands and Consumers
Key Insight
- Fast growing middle class in China will expand to 350m in 2016
Innovation/Strategy
- To provide solutions to exporters who do business in Asia, to protect their brands and connect to consumers
YPB developed and owns world’s first End-to-End Anti-Counterfeit, Brand Protection solution
To view the full presentation, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
